Producción Científica Profesorado

Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats

Molina Trinidad, Eva María


Eva M. Molina Trinidad, Consuelo Arteaga de Murphy, Helgi Jung-Cook Eduardo Murphy-Stack, Martha Pedraza-López, José Luis Morales-Márquez, Guadalupe Vertiz Serrano. Therapeutic 188Re-lanreotide: Determination of Radiopharmacokinetics Parameters in rats. Journal Pharmacy and Pharmacology. 2010, 62:1-6. DOI: 10.1211/jpp.62.04.0007


Objectives The radiopharmacokinetic parameters of the therapeutic radiopharmaceutical 188Re-lanreotide were compared in rats implanted with hepatocarcinoma tumours (n= 18) and healthy rats (n= 18).Methods Rats were injected with approximately 1.8 MBq 188Re-lanreotide (0.1 ml) via the tail vein and blood samples were obtained. The activity per gram of tissue (%IA/g) was calculated and the radiopharmacokinetic parameters determined. Data were fitted using a two-compartment model.Key findings Significant differences were found between healthy and hepatoma rats for beta elimination half-life (22.56 vs 48.14 h); transference constants K10 (ke) (6.44 vs 3.05 h-1) and K12 (2.76 vs 7.09 h-1); volume of distribution (2.06 vs 5.45 ml); mean residence time (66.58 vs 95.50 h) and apparent volume of distribution at steady state (131.30 vs 810.37 ml). The tumour/organ ratios after 24 h were 11.20 for tumour/muscle, 8.00 for tumour/liver and 7.72 for tumour/bone. The scintigraphic images obtained therefore had high resolution.Conclusions188Re-lanreotide had a prolonged beta elimination half-life and increased volume of distribution in rats with hepatocellular carcinoma. This may be beneficial in the diagnosis and therapy of metastatic lesions in patients with cancer.

Producto de Investigación

Artículos relacionados

Gold nanoparticles conjugated to benzoylmercaptoacetyltriglycine and L-cysteine methylester

Tacrolimus Levels in Adult Patients With Renal Transplant

Educación al Paciente Diabético

Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats

Therapeutic Drug Monitoring of Vancomycin

Radiopharmacokinetic and dosimetric parameters of 188Re-lanreotide in athymic mice with induced huma...